课题基金 / 基金详情

PHASE I/II STUDY OF OSI-774 AND CCI-779 IN RECURRENT MALIGNANT GLIOMA

PHASE I/II STUDY OF OSI-774 AND CCI-779 IN RECURRENT MALIGNANT GLIOMA
OSI-774 和 CCI-779 在复发性恶性胶质瘤中的 I/II 期研究
批准号:
7607538
负责人:
MINESH P. MEHTA
金额:
$0.49万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

MINESH P. MEHTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. (from ClinicalTrials.gov website) Erlotinib and temsirolimus and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. This Phase I/II trial is studying the side effects and best dose of temsirolimus when given together with erlotinib and to see how well they work in treating patients with recurrent malignant glioma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE II STUDY OF XRT + LOW-DOSE TEMOZOLOMIDE FOLLOWED BY TEMOZOLOMIDE + CPT-11
  • 批准号:
    7607532
  • 项目类别:
  • 资助金额:
    $0.09万
  • 财政年份:
    2006
  • 负责人:
    MINESH P. MEHTA
  • 依托单位:
PHASE II TRIAL OF EMD 121974 FOR RECURRENT GLIOBLASTOMA
  • 批准号:
    7607531
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    2006
  • 负责人:
    MINESH P. MEHTA
  • 依托单位:
PHASE I/II TRIAL OF CPT-11 AND TEMOZOLOMIDE IN RECURRENT MALIGNANT GLIOMA
  • 批准号:
    7204329
  • 项目类别:
  • 资助金额:
    $1.8万
  • 财政年份:
    2005
  • 负责人:
    MINESH P. MEHTA
  • 依托单位:
PHASE I/II TRIAL OF R115777 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
  • 批准号:
    7204322
  • 项目类别:
  • 资助金额:
    $0.15万
  • 财政年份:
    2005
  • 负责人:
    MINESH P. MEHTA
  • 依托单位:
海外基金